Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD5492 |
Synonyms | |
Therapy Description |
AZD5492 is a trispecific target-induced T-cell activating nanobody targeting CD20 on tumor cells, TCR, and CD8, which potentially induces activation of T-cells and enhances antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12, NCI Drug Dictionary). |